Project Grant R56ES035376

Award Date 9/22/23
Completion Date 8/31/24
Dollars Obligated $158K
Federal Grant Program
93.113
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
This $776,150.33 Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program supports research to examine the relationships between exposure to the antimicrobial and endocrine disrupting compound triclosan, pubertal hormones, the adolescent gut microbiome, and neurobehavior. The primary awardee, the University of Massachusetts, will leverage a longitudinal birth cohort study to profile the adolescent gut...
This Project Grant award of $413,860, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to investigate the interactions between non-tuberculous mycobacteria (NTM) infections, specifically Mycobacterium abscessus (MAB), and the onset/progression of systemic lupus erythematosus (SLE). The research will utilize preclinical mouse models and ex vivo models with fetal...
The National Institute of Environmental Health Sciences (NIEHS) awarded a $794,841 Project Grant (CFDA 93.113 - Environmental Health) to the University of California, San Diego (UCSD) to investigate the effects of early-life triclosan exposure through lactation on the gut-liver axis and its implications for the development of metabolic dysfunction-associated steatotic liver disease (MASLD) in adults. The research aims to elucidate the mechanisms by which lactational triclosan exposure...
This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $102,399 to Wright State University to investigate the role of extracellular, UV-damaged DNA in triggering systemic inflammatory responses in photosensitive autoimmune disorders like lupus. The research aims to demonstrate the presence of cyclobutane pyrimidine dimers (CPDs) in extracellular vesicles and correlate this DNA damage with...
This Project Grant award of $622,235 from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program supports research to define the impact of developmental herbicide exposures on gut microbiome physiology and interactions with health. The project aims to investigate how interactions between herbicide exposure, the microbiome, and the host promote adiposity, with a focus on understanding the mechanistic links between...
The National Institute of Environmental Health Sciences (NIEHS) awarded a $480,000 Project Grant under the Environmental Health (CFDA 93.113) federal grant program to the Scripps Research Institute in La Jolla, CA. The grant, with a project period from August 2024 to July 2026, will fund research to develop a novel experimental model of severe inflammatory arthritis induced by pulmonary exposure to crystalline silica. The goal is to better understand how environmental exposures can contribute to...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $555,774.00 to the University of Alabama at Birmingham (UAB) over a 5-year period starting November 19, 2024. The award supports research to investigate the role of the aryl hydrocarbon receptor (AhR) pathway in regulating the development of T-bet+ B cells, which are implicated in the pathogenesis of systemic lupus...
This $2,166,750 project grant from the National Institutes of Health's National Institute of Environmental Health Sciences will fund research into the role of the gut microbiome in host adaptation to environmental xenobiotics. The University of California, Berkeley will explore how exposure to commonly used pesticides shapes the gut microbiome of the model organism C. elegans, and the long-term health consequences for the host. Researchers will characterize microbiome-assisted adaptation to...
This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health (CFDA 93.113) federal grant program, will support research investigating the complex interactions between prenatal metal exposures, gut microbiome composition, and childhood telomere length attrition. The $445,240 award, granted on April 29, 2025, will fund a study conducted by the Icahn School of Medicine at Mount Sinai. The research aims to identify associations between...
The University of Massachusetts Medical School was awarded a $494,929 Project Grant from the National Institute of Allergy and Infectious Diseases to study the role of Toll-like receptors, type II interferon and type III interferon in a murine model of autoinflammation. The grant will support research exploring the effector mechanisms responsible for inducing and regulating cutaneous lupus using genetically modified mice with discriminating mutations. Specifically, the researchers will use...

This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health program (CFDA 93.113) is supporting research at the University of Texas Medical Branch at Galveston (UTMB) to investigate the role of gut microbiome dysbiosis in trichloroethylene-mediated autoimmunity.

The $158,157 award will fund a study to determine how exposure to the environmental contaminant trichloroethylene (TCE) impacts the gut microbiome and contributes to the development of systemic lupus erythematosus (SLE)-like autoimmune disease in MRL+/+ mice. The researchers will characterize TCE-induced gut microbiome changes, evaluate how these changes affect intestinal integrity and mucosal immunity, and assess whether restoring short-chain fatty acid imbalances or probiotic therapy can mitigate TCE-mediated autoimmunity. Successful completion of this research is expected to elucidate novel mechanisms by which gut dysbiosis contributes to TCE-induced autoimmunity and inform the development of microbiome-targeted therapies for SLE.

Generated 7/16/24, 6:15 AM